Research Articles Library
Literature Analysis Tools
Advanced Search
Filter by PMID, year, source, DOI and other criteria
Literature Analysis
Analyze research trends and hotspots
Batch Export
Export search results to Excel/PDF
Ulcerative colitis complicated with hypermucinous dysplasia
Publication Year: 2025 Source: Rev Esp Enferm Dig PMID: 38469865
Patients with ulcerative colitis are at increased risk for colorectal neoplasia compared to the general population. The risk factors include family history of colorectal cancer, wide extent of colitis, disease duration, cumulative inflammatory burden, and primary sclerosing cholangitis. Here, we report a case of colorectal neoplasia developed in a patient …
Uptake and safety of pneumococcal vaccination in adults with immune-mediated inflammatory diseases: a UK wide observational study
Publication Year: 2025 Source: Rheumatology (Oxford) PMID: 38479823 DOI: 10.1093/rheumatology/keae160
OBJECTIVE: The uptake and safety of pneumococcal vaccination in people with immune-mediated inflammatory diseases (IMIDs) is poorly understood. We investigated the UK-wide pneumococcal vaccine uptake in adults with IMIDs and explored the association between vaccination and IMID flare. METHODS: Adults with IMIDs diagnosed on or before 1 September 2018, prescribed …
Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero
Publication Year: 2025 Source: Clin Gastroenterol Hepatol PMID: 38492905
No Abstract
Children and Adolescents Diagnosed With Inflammatory Bowel Disease Are at Increased Risk of Developing Diseases With a Possible Autoimmune Pathogenesis
Publication Year: 2025 Source: Inflamm Bowel Dis PMID: 38507606 DOI: 10.1093/ibd/izae047
BACKGROUND: The development of diseases with a possible autoimmune pathogenesis is common in adults with inflammatory bowel disease (IBD). In early onset IBD, it may differ but the evidence is sparse. We aimed to investigate the risk and time span from IBD diagnosis to outcomes with different associated disorders with …
Clinical Pharmacist Counselling Improves Long-term Medication Safety and Patient-reported Outcomes in Anti-TNF-treated Patients With Inflammatory Bowel Diseases: The Prospective, Randomized AdPhaNCED Trial
Publication Year: 2025 Source: Inflamm Bowel Dis PMID: 38507608 DOI: 10.1093/ibd/izae040
BACKGROUND: Antitumor necrosis factor (anti-TNF) antibody treatment has led to marked improvements in the management of patients with inflammatory bowel diseases (IBDs). Nevertheless, anti-TNF therapy is associated with potential adverse drug reactions (ADRs). Our prospective, randomized trial investigated the effect of intensified clinical pharmacist counselling in a multidisciplinary team on …
Ustekinumab Drug Levels and Outcomes in Inflammatory Bowel Disease
Publication Year: 2025 Source: J Clin Gastroenterol PMID: 38300529 DOI: 10.1097/MCG.0000000000001978
BACKGROUND: Data regarding the utility of therapeutic drug monitoring with ustekinumab (UST) are sparse. Our aim was to determine the correlation of UST levels with outcomes in a cohort of patients with inflammatory bowel disease (IBD). METHODS: This was a multicenter, retrospective study of all patients with IBD who received …
Tofacitinib in Pregnancy: Assessing Pregnancy and Infant Outcomes, Cord Blood, and Breast Milk Concentrations
Publication Year: 2025 Source: Clin Gastroenterol Hepatol PMID: 38309493 DOI: 10.1016/j.cgh.2024.01.019
Janus kinase (JAK) inhibitors are effective anti-inflammatory agents for treatment of ulcerative colitis (UC).(1) According to drug regulatory agencies and international guidelines, JAK inhibitors should be avoided during pregnancy and lactation.(2-4) The existing evidence on safety of JAK inhibitors during pregnancy is scarce and almost exclusively limited to tofacitinib.(4-7).
Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship
Publication Year: 2025 Source: Minerva Gastroenterol (Torino) PMID: 38324328 DOI: 10.23736/S2724-5985.23.03605-7
Primary sclerosing cholangitis (PSC) is a rare liver disorder characterized by biliary ducts inflammation, fibrosis and consequently chronic cholestasis, which progressively lead to liver cirrhosis. The main feature of PSC is the frequent association with inflammatory bowel disease (IBD), with an estimated prevalence of around 70% of the cases. This …
Vedolizumab Does Not Affect Antibody Secreting Cell Recruitment to the Lactating Mammary Gland of Mothers With Inflammatory Bowel Disease
Publication Year: 2025 Source: Inflamm Bowel Dis PMID: 38334263 DOI: 10.1093/ibd/izae023
No Abstract
Therapeutic application and potential mechanism of plant-derived extracellular vesicles in inflammatory bowel disease
Publication Year: 2025 Source: J Adv Res PMID: 38341033 DOI: 10.1016/j.jare.2024.01.035
BACKGROUND: Plant-derived extracellular vesicles (PDEVs) are membrane vesicles characterized by a phospholipid bilayer as the basic skeleton that is wrapped by various functional components of proteins and nucleic acids. An increasing number of studies have confirmed that PDEVs can be a potential treatment of inflammatory bowel disease (IBD) and can, …
Need more literature?
The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.
External Resources: Access comprehensive literature databases worldwide